BUZZ-Welsh Carson-backed Lumexa Imaging poised for muted Nasdaq debut

Reuters12-12

** Diagnostic imaging services provider Lumexa Imaging's LMRI.O shares poised to open slightly above offer price in its Nasdaq debut

** Stock indicated to open at $18.75 apiece vs $18.50 IPO price

** Backed by private equity firm Welsh, Carson, Anderson & Stowe (WCAS), LMRI sold 25 million shares at the midpoint of its marketed range of $17 to $20 per share to raise $462.5 million

** The U.S. IPO market is in the penultimate week of the year with robo-advisor Wealthfront poised to go public in New York on Friday

** Formerly known as US Radiology Specialists, LMRI was formed in 2018 by Charlotte Radiology and WCAS

** LMRI has expanded rapidly in recent years and its U.S. footprint spans 184 centers across 13 states

** Barclays, J.P. Morgan and Jefferies were joint lead book-running managers for offering

(Reporting by Arasu Kannagi Basil in Bengaluru)

((ArasuKannagi.Basil@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2590201510?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-12 00:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2590201510","market":"us","top_or_hot":-1,"title":"BUZZ-Welsh Carson-backed Lumexa Imaging poised for muted Nasdaq debut","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Welsh Carson-backed Lumexa Imaging poised for muted Nasdaq debut</title></head><body><p>** Diagnostic imaging services provider Lumexa Imaging's <span>LMRI.O</span> shares poised to open slightly above offer price in its Nasdaq debut</p><p>** Stock indicated to open at $18.75 apiece vs $18.50 IPO price</p><p>** Backed by private equity firm Welsh, Carson, Anderson &amp; Stowe (WCAS), LMRI <span>sold</span> 25 million shares at the midpoint of its <span>marketed range</span> of $17 to $20 per share to raise $462.5 million</p><p>** The U.S. IPO market is in the penultimate week of the year with robo-advisor Wealthfront poised to go public in New York on Friday</p><p>** Formerly known as US Radiology Specialists, LMRI was formed in 2018 by Charlotte Radiology and WCAS</p><p>** LMRI has expanded rapidly in recent years and its U.S. footprint spans 184 centers across 13 states</p><p>** Barclays, J.P. Morgan and Jefferies were joint lead book-running managers for offering</p><p>(Reporting by Arasu Kannagi Basil in Bengaluru)</p><p>((ArasuKannagi.Basil@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Welsh Carson-backed Lumexa Imaging poised for muted Nasdaq debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Welsh Carson-backed Lumexa Imaging poised for muted Nasdaq debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-12 00:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Welsh Carson-backed Lumexa Imaging poised for muted Nasdaq debut</title></head><body><p>** Diagnostic imaging services provider Lumexa Imaging's <span>LMRI.O</span> shares poised to open slightly above offer price in its Nasdaq debut</p><p>** Stock indicated to open at $18.75 apiece vs $18.50 IPO price</p><p>** Backed by private equity firm Welsh, Carson, Anderson &amp; Stowe (WCAS), LMRI <span>sold</span> 25 million shares at the midpoint of its <span>marketed range</span> of $17 to $20 per share to raise $462.5 million</p><p>** The U.S. IPO market is in the penultimate week of the year with robo-advisor Wealthfront poised to go public in New York on Friday</p><p>** Formerly known as US Radiology Specialists, LMRI was formed in 2018 by Charlotte Radiology and WCAS</p><p>** LMRI has expanded rapidly in recent years and its U.S. footprint spans 184 centers across 13 states</p><p>** Barclays, J.P. Morgan and Jefferies were joint lead book-running managers for offering</p><p>(Reporting by Arasu Kannagi Basil in Bengaluru)</p><p>((ArasuKannagi.Basil@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1035777561.USD","symbol_name":"AB SICAV I - EUROPEAN EQUITY PORTFOLIO \"A\" (USDHDG) ACC","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nL6N3XH0Z7:1","article_id":"2590201510","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2590201510","pubTimestamp":1765470868,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Welsh Carson-backed Lumexa Imaging poised for muted Nasdaq debut** Diagnostic imaging services provider Lumexa Imaging's LMRI.O shares poised to open slightly above offer price in its Nasdaq debut** Stock indicated to open at $18.75 apiece vs $18.50 IPO price** Backed by private equity firm Welsh, Carson, Anderson & Stowe , LMRI sold 25 million shares at the midpoint of its marketed range of $17 to $20 per share to raise $462.5 million** The U.S. IPO market is in the penultimate week of the year with robo-advisor Wealthfront poised to go public in New York on Friday** Formerly known as US Radiology Specialists, LMRI was formed in 2018 by Charlotte Radiology and WCAS** LMRI has expanded rapidly in recent years and its U.S. footprint spans 184 centers across 13 states** Barclays, J.P. Morgan and Jefferies were joint lead book-running managers for offering","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1035777561.USD":"AB SICAV I - EUROPEAN EQUITY PORTFOLIO \"A\" (USDHDG) ACC","LU0048578792.EUR":"FIDELITY EUROPEAN GROWTH \"A\" INC","LU0106831901.USD":"贝莱德世界金融基金A2","LU0047473722.EUR":"HSBC GIF EUROPE VALUE \"PD\" (EUR) INC","LU1668664300.SGD":"Blackrock World Financials A2 SGD-H","LU0171281750.USD":"BGF EUROPEAN VALUE \"A2\" (USD) ACC","LU1023061473.USD":"BGF EUROPEAN VALUE \"A2\" (USD HDG) ACC","LU0161305163.EUR":"SCHRODER ISF EUROPEAN VALUE \"A\" (EUR) ACC","BK4107":"财产与意外伤害保险","LU1064927863.SGD":"JPMorgan Funds - Europe Dynamic A (acc) SGD-H","LU0345777659.USD":"NINETY ONE GSF EUROPEAN EQUITY \"A\" (USD) INC","LU0047473722.SGD":"HSBC GIF EUROPE VALUE \"PD\" (SGD) INC","LU1791807156.HKD":"BGF WORLD FINANCIALS \"A2\" (HKDHDG) ACC","LU0997586606.USD":"FIDELITY EUROPEAN GROWTH \"A\" (USDHDG) ACC","LU0964806797.USD":"UBS (LUX) EQUITY FUND - EUROPEAN OPPORTUNITY SUSTAINABLE (EUR) \"P\" (USHDG) ACC","LU0550127509.SGD":"富达欧洲增长基金SGD","LU0987226296.USD":"JPM EUROPE DYNAMIC  \"A\" (USDHEDGED) ACC","LU0345770308.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) ACC","LU0345770993.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) INC","BK5152":"综合性银行","AMSF":"Amerisafe Inc","LU2646069778.SGD":"JPM EUROPE DYNAMIC \"A\" (SGD) ACC","BARC.UK":"巴克莱银行","LU0345777147.USD":"NINETY ONE GSF EUROPEAN EQUITY \"A\" (USD) ACC","LU1023061713.HKD":"BGF EUROPEAN VALUE \"A2\" (HKDHDG) ACC","LU1078025761.USD":"NINETY ONE GSF EUROPEAN EQUITY \"A\" (USDHDG) ACC","LMRI":"Lumexa Imaging Holdings"},"translate_title":"BUZZ-Welsh Carson支持的Lumexa Imaging准备在纳斯达克低调亮相","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AMSF":0.9,"LMRI":0.9,"BARC.UK":0.9},"content_text":"BUZZ-Welsh Carson-backed Lumexa Imaging poised for muted Nasdaq debut** Diagnostic imaging services provider Lumexa Imaging's LMRI.O shares poised to open slightly above offer price in its Nasdaq debut** Stock indicated to open at $18.75 apiece vs $18.50 IPO price** Backed by private equity firm Welsh, Carson, Anderson & Stowe (WCAS), LMRI sold 25 million shares at the midpoint of its marketed range of $17 to $20 per share to raise $462.5 million** The U.S. IPO market is in the penultimate week of the year with robo-advisor Wealthfront poised to go public in New York on Friday** Formerly known as US Radiology Specialists, LMRI was formed in 2018 by Charlotte Radiology and WCAS** LMRI has expanded rapidly in recent years and its U.S. footprint spans 184 centers across 13 states** Barclays, J.P. Morgan and Jefferies were joint lead book-running managers for offering(Reporting by Arasu Kannagi Basil in Bengaluru)((ArasuKannagi.Basil@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2590201510","isCrawlerRequest":true}